Balancing Innovation and Patient Safety in Trials

I’ve been thinking a lot about how we can push the boundaries of medical device innovation while ensuring patient safety throughout clinical trials. During a recent study I was involved in, we had to pivot our technical protocol midway due to unforeseen device malfunctions, which sparked a lot of discussion among our team about how best to manage risks without stifling progress. How do you all handle these kinds of challenges in your research?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‍​⁠​​​⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​‌​‌‍‌‌‌‌‍‍‌⁠‍‌‌‌​​‌​‌​​⁠​​‌​‌‌‌​⁠‍‌‍‍​​⁠‌⁠‌‍‍​​⁠‌‍‌‍​⁠​⁠‌‌‌​‌⁠​‍​‍‌⁠⁠‌​

I completely agree about managing risks without stifling progress. In one trial, we implemented real-time monitoring to catch issues early, which helped maintain patient safety while keeping the project on track. Have you ever tried a similar approach?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌⁠​⁠​‌​⁠‌‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‍​​⁠​‍​⁠‌‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​⁠‌‍‌​⁠‌‌‍​‌​⁠‌​​⁠‍​‌‍‌​‌‌‍‍‌‍‌​‌⁠‌‌‌‍‍​‌⁠​‌‌​‍⁠‌‍‌‌‌​‍‍​⁠‌​‌‌‌⁠​‍​‍‌⁠⁠‌